These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2986091

  • 1. [Corticotropin releasing factor].
    Conte-Devolx B, Oliver C, Rey M, Guillaume V, Castanas E, Giraud P, Boudouresque F, Grino M.
    Presse Med; 1985 Mar 30; 14(13):737-41. PubMed ID: 2986091
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The hypothalamo-pituitary-adrenocortical system.
    Hodges JR.
    Br J Anaesth; 1984 Jul 30; 56(7):701-10. PubMed ID: 6329252
    [Abstract] [Full Text] [Related]

  • 5. Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats.
    Hauger RL, Thrivikraman KV, Plotsky PM.
    Endocrinology; 1994 Mar 30; 134(3):1528-36. PubMed ID: 8119195
    [Abstract] [Full Text] [Related]

  • 6. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1989 Nov 30; 125(5):2445-53. PubMed ID: 2551652
    [Abstract] [Full Text] [Related]

  • 7. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats.
    Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, Demura H.
    Endocrinology; 1994 Nov 30; 135(5):2177-82. PubMed ID: 7956940
    [Abstract] [Full Text] [Related]

  • 8. Alteration of pituitary-adrenal responses to adrenalectomy by the immunological targeting of CRF neurons.
    Menzaghi F, Burlet A, Chapleur M, Nicolas JP, Burlet C.
    Neurosci Lett; 1992 Jan 20; 135(1):49-52. PubMed ID: 1311823
    [Abstract] [Full Text] [Related]

  • 9. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL.
    Am J Psychiatry; 1984 May 20; 141(5):619-27. PubMed ID: 6324597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Corticoliberin--structure, occurrence, properties and clinical use].
    Miśkowiak B.
    Endokrynol Pol; 1985 May 20; 36(3):169-85. PubMed ID: 3000753
    [No Abstract] [Full Text] [Related]

  • 14. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb 20; 256(2):787-94. PubMed ID: 1847212
    [Abstract] [Full Text] [Related]

  • 15. Effect of chronic active immunization anti-corticotropin-releasing factor on the pituitary-adrenal function in the sheep.
    Guillaume V, Conte-Devolx B, Magnan E, Boudouresque F, Grino M, Cataldi M, Muret L, Priou A, Deprez P, Figaroli JC.
    Endocrinology; 1992 Apr 20; 130(4):2291-8. PubMed ID: 1312453
    [Abstract] [Full Text] [Related]

  • 16. Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications.
    Kageyama K, Tamasawa N, Suda T.
    Stress; 2011 Jul 20; 14(4):357-67. PubMed ID: 21438777
    [Abstract] [Full Text] [Related]

  • 17. [Experimental studies on the ACTH secretion mechanism].
    Oimomi M.
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec 20; 44(9):1056-75. PubMed ID: 4304530
    [No Abstract] [Full Text] [Related]

  • 18. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 20; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer.
    Redei E, Paré WP, Aird F, Kluczynski J.
    Am J Physiol; 1994 Feb 20; 266(2 Pt 2):R353-60. PubMed ID: 8141389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.